Growing community of inventors

Kobenhavn, Denmark

Paul Stanley Bury

Average Co-Inventor Count = 3.35

ph-index = 14

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 334

Paul Stanley BuryPer Sauerberg (24 patents)Paul Stanley BuryLone Jeppesen (24 patents)Paul Stanley BuryIngrid Pettersson (9 patents)Paul Stanley BuryPoul Jacobsen (8 patents)Paul Stanley BuryJohn Patrick Mogensen (8 patents)Paul Stanley BuryLise Brown Christiansen (8 patents)Paul Stanley BuryAnders Bendtz Kanstrup (8 patents)Paul Stanley BurySvend Treppendahl (6 patents)Paul Stanley BuryAnthony Murray (4 patents)Paul Stanley BuryAnker S Jorgensen (2 patents)Paul Stanley BuryPaul Stanley Bury (34 patents)Per SauerbergPer Sauerberg (99 patents)Lone JeppesenLone Jeppesen (60 patents)Ingrid PetterssonIngrid Pettersson (30 patents)Poul JacobsenPoul Jacobsen (28 patents)John Patrick MogensenJohn Patrick Mogensen (26 patents)Lise Brown ChristiansenLise Brown Christiansen (19 patents)Anders Bendtz KanstrupAnders Bendtz Kanstrup (18 patents)Svend TreppendahlSvend Treppendahl (26 patents)Anthony MurrayAnthony Murray (33 patents)Anker S JorgensenAnker S Jorgensen (19 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novo Nordisk A/s (23 from 1,778 patents)

2. Other (9 from 832,912 patents)

3. Btg International Limited (2 from 250 patents)

4. Karo Bio Ab (1 from 34 patents)


34 patents:

1. 8389714 - Process for the preparation of 17-0-vinyl-triflates as intermediates

2. 8236946 - Process for the preparation of 17-0-vinyl-triflates as intermediates

3. 7220877 - Compounds, their preparation and use

4. 7202213 - Combination therapy using a dual PPAR-α/PPAR-γ activator and a GLP-1 derivative for the treatment of metabolic syndrome and related diseases and disorders

5. 7067530 - Compounds, their preparation and use

6. 6972294 - Compounds, their preparation and use

7. 6869967 - Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives

8. 6867218 - Compounds, their preparation and use

9. 6723731 - Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)

10. 6703401 - Compounds, their preparation and use

11. 6683111 - Compounds, their preparation and use

12. 6602901 - Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)

13. 6569901 - Alkynyl-substituted propionic acid derivatives, their preparation and use

14. 6555577 - Compounds, their preparation and use

15. 6534517 - Compounds, their preparation and use

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/10/2026
Loading…